Weaver Consulting Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Hold |
|
|||||
|
2025
Q1 | $19.7K | Hold |
|
|||||
|
2024
Q4 | $35.5K | Sell |
|
|||||
|
2024
Q3 | $54K | Hold |
|
|||||
|
2024
Q2 | $79.3K | Buy |
|
|||||
|
2024
Q1 | $113K | Hold |
|
|||||
|
2023
Q4 | $54.4K | Buy |
|
|||||
|
2023
Q3 | $19.9K | Buy |
|
|||||
|
2023
Q2 | $133K | Buy |
|
|||||
|
2023
Q1 | $210K | Sell |
|
|||||
|
2022
Q4 | $108K | Sell |
|
|||||
|
2022
Q3 | $415K | Sell |
|
|||||
|
2022
Q2 | $289K | Sell |
|
|||||
|
2022
Q1 | $437K | Sell |
|
|||||
|
2021
Q4 | $622K | Buy |
|
|||||
|
2021
Q3 | $170K | Buy |
|
|||||
|
2021
Q2 | $186K | Sell |
|
|||||
|
2021
Q1 | $192K | Buy |
|